Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
- PMID: 11408299
- PMCID: PMC32306
- DOI: 10.1136/bmj.322.7300.1447
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
Abstract
Objective: To examine the relation of midlife raised blood pressure and serum cholesterol concentrations to Alzheimer's disease in later life.
Design: Prospective, population based study.
Setting: Populations of Kuopio and Joensuu, eastern Finland.
Participants: Participants were derived from random, population based samples previously studied in a survey carried out in 1972, 1977, 1982, or 1987. After an average of 21 years' follow up, a total of 1449 (73%) participants aged 65-79 took part in the re-examination in 1998.
Main outcome measures: Midlife blood pressure and cholesterol concentrations and development of Alzheimer's disease in later life.
Results: People with raised systolic blood pressure (>/=160 mm Hg) or high serum cholesterol concentration (>/=6.5 mmol/l) in midlife had a significantly higher risk of Alzheimer's disease in later life, even after adjustment for age, body mass index, education, vascular events, smoking status, and alcohol consumption, than those with normal systolic blood pressure (odds ratio 2.3, 95% confidence interval 1.0 to 5.5) or serum cholesterol (odds ratio 2.1, 1.0 to 4.4). Participants with both of these risk factors in midlife had a significantly higher risk of developing Alzheimer's disease than those with either of the risk factors alone (odds ratio 3.5, 1.6 to 7.9). Diastolic blood pressure in midlife had no significant effect on the risk of Alzheimer's disease.
Conclusion: Raised systolic blood pressure and high serum cholesterol concentration, and in particular the combination of these risks, in midlife increase the risk of Alzheimer's disease in later life.
Similar articles
-
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.Ann Intern Med. 2002 Aug 6;137(3):149-55. doi: 10.7326/0003-4819-137-3-200208060-00006. Ann Intern Med. 2002. PMID: 12160362
-
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.Arch Neurol. 2005 Oct;62(10):1556-60. doi: 10.1001/archneur.62.10.1556. Arch Neurol. 2005. PMID: 16216938
-
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.Neurology. 2007 Mar 6;68(10):751-6. doi: 10.1212/01.wnl.0000256368.57375.b7. Neurology. 2007. PMID: 17339582
-
Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention.CNS Drugs. 2002;16(7):435-44. doi: 10.2165/00023210-200216070-00001. CNS Drugs. 2002. PMID: 12056919 Review.
-
Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis.J Alzheimers Dis. 2014;42(4):1295-310. doi: 10.3233/JAD-140954. J Alzheimers Dis. 2014. PMID: 25024338 Review.
Cited by
-
Associations Between High-Density Lipoprotein Cholesterol Efflux and Brain Grey Matter Volume.J Clin Med. 2024 Oct 18;13(20):6218. doi: 10.3390/jcm13206218. J Clin Med. 2024. PMID: 39458168 Free PMC article.
-
Enhancing cognitive performance and mitigating dyslipidemia: the impact of moderate aerobic training on sedentary older adults.BMC Geriatr. 2024 Aug 13;24(1):678. doi: 10.1186/s12877-024-05276-8. BMC Geriatr. 2024. PMID: 39138393 Free PMC article.
-
Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?Pharmaceutics. 2024 May 24;16(6):708. doi: 10.3390/pharmaceutics16060708. Pharmaceutics. 2024. PMID: 38931832 Free PMC article. Review.
-
Cholesterol profiling reveals 7β-hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer's disease.Psychiatry Clin Neurosci. 2024 Aug;78(8):473-481. doi: 10.1111/pcn.13706. Epub 2024 Jun 24. Psychiatry Clin Neurosci. 2024. PMID: 38923201 Free PMC article.
-
Serum proteomics study on cognitive impairment after cardiac valve replacement surgery: a prospective observational study.PeerJ. 2024 Jun 18;12:e17536. doi: 10.7717/peerj.17536. eCollection 2024. PeerJ. 2024. PMID: 38912047 Free PMC article.
References
-
- Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141–1145. - PubMed
-
- Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49–55. - PubMed
-
- Notkola I-L, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E4, and Alzheimer's disease. Neuroepidemiology. 1998;17:14–20. - PubMed
-
- Braak E, Griffing K, Arai K, Bohl J, Bratzke H, Braak H. Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci. 1999;249(suppl 3):14–22. - PubMed
-
- Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in North-Karelia and in other areas of Finland. Int J Epidemiol. 1994;23:495–504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical